SUBSCRIBE
SUBSCRIBE

Pancreatic cancer

MORE FROM BIOSPACE INSIGHTS
Pictured: Gloved hands amid a collage of cancer treatments
Drug Development
Vaccines, Next-Gen Approaches Target the Toughest Cancers: AACR
Data presented at the American Association for Cancer Research’s annual meeting sparked hope that we could be getting closer to treating pancreatic cancer, glioblastoma and other particularly difficult tumors.
April 11, 2024
 · 
3 min read
 · 
Heather McKenzie
PRESS RELEASES
Press Releases
Can-Fite: Pancreatic Carcinoma Phase IIa Clinical Study with Namodenoson Received Regulatory Authorization from the Israeli Ministry of Health
September 16, 2024
 · 
6 min read
Press Releases
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
September 9, 2024
 · 
7 min read
Press Releases
AIM ImmunoTech Announces Print Publication and Further Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
August 20, 2024
 · 
4 min read
Press Releases
Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 7, 2024
 · 
10 min read
Press Releases
FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
July 31, 2024
 · 
8 min read
Press Releases
Can-Fite Provides Namodenoson Patent Update
July 29, 2024
 · 
5 min read
Press Releases
Ipsen delivers strong results in the first half of 2024, progresses on launches and upgrades its full-year guidance
July 25, 2024
 · 
10 min read
Press Releases
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
July 18, 2024
 · 
8 min read
Press Releases
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
July 12, 2024
 · 
6 min read
Drug Development
RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®
July 9, 2024
 · 
9 min read
Drug Development
CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments
July 1, 2024
 · 
4 min read
BioForest
Molecular You Announces Breakthrough in Early Detection of Pancreatic Cancer
April 22, 2024
 · 
3 min read
Drug Development
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
March 25, 2024
 · 
4 min read
Lone Star Bio
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
March 14, 2024
 · 
4 min read
Drug Development
AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
February 14, 2024
 · 
3 min read